Free Trial

The 12 Most-Hated Stocks on Wall Street - 5 of 12

 
 

IQVIA (NYSE:IQV)

Number of Downgrades
20 (in the last 90 days)
Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
18 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$255.82 (29.7% Upside)

About IQVIA

IQVIA logoIQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
12/20/2024StephensInitiated CoverageOverweight$250.00
12/13/2024Bank of AmericaLower Price TargetBuy ➝ Buy$255.00 ➝ $235.00
12/12/2024Truist FinancialLower Price TargetBuy ➝ Buy$265.00 ➝ $261.00
12/11/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$270.00 ➝ $270.00
12/11/2024Robert W. BairdLower Price TargetNeutral ➝ Neutral$213.00 ➝ $212.00
12/11/2024William BlairReiterated RatingOutperform
12/4/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$270.00 ➝ $270.00
11/19/2024Leerink PartnersReiterated RatingOutperform ➝ Outperform$260.00 ➝ $248.00
11/5/2024JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$279.00 ➝ $240.00
11/4/2024Truist FinancialLower Price TargetBuy ➝ Buy$286.00 ➝ $265.00
 

Your chance to get on the next “60-Second Trade” (Ad)

Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!

Just head over here!